Clinical Application Advantages of Diffuser Fiber in Minimally Invasive Tumor Phototherapy – Clinical Practice Summary

Keywords:Diffuser Fiber  Time:23-07-2026

As a attending physician engaged in tumor minimally invasive treatment and photodynamic therapy research for many years, I have applied various optical fiber light-delivery systems in hundreds of clinical cases of interstitial tumor therapy. In the comparative analysis of clinical efficacy, surgical operability, and postoperative complication rates, high-precision diffuser fiber has shown irreplaceable advantages over traditional point-light and linear light optical fibers.

Tumor interstitial phototherapy, represented by interstitial Photodynamic Therapy (iPDT) and interstitial Laser Photocoagulation (ILP), relies entirely on implantable light-delivery devices to transmit therapeutic light to deep tumor lesions. The performance of diffuser fiber directly affects the accuracy of lesion coverage, the effectiveness of tumor cell inactivation, and the protection of surrounding normal tissues.

The biggest clinical pain point of traditional optical fibers in tumor treatment is limited light coverage. Point-emission fibers can only form a small-range light focal area, which is difficult to cover irregular tumor tissues, especially for medium and large-sized solid tumors and scattered metastatic tumor nodules. Multiple puncture implantations are required to complete full lesion coverage, which significantly increases intraoperative trauma, operation time, and the risk of bleeding and infection.

Linear ordinary diffuser fibers have uneven energy distribution, as verified in clinical optical detection data: the light fluence rate at the proximal end can exceed 60 J·cm⁻², far higher than the therapeutic threshold, while the distal end is lower than the effective dose of 20 J·cm⁻², resulting in partial tumor cell survival and postoperative recurrence.

Medical-grade diffuser fiber solves the above clinical pain points through optimized structural and optical design. Its 360° uniform radial light emission characteristic can form a regular and stable therapeutic light field in the interstitial space, covering irregular tumor three-dimensional space with a single implantation. As shown in the clinical data comparison table below, premium diffuser fiber has significant advantages in light dose uniformity, lesion coverage efficiency, and complication control compared with traditional products in breast tumor and subcutaneous metastatic tumor iPDT treatment:

Performance Index	Traditional Ordinary Diffuser Fiber	Medical-Grade Premium Diffuser Fiber	Clinical Benefit
Axial Light Dose Uniformity	Unstable, Proximal-Distal Difference >45%	High Uniformity, Difference < 12%	Avoid partial treatment failure and normal tissue burns
Effective Lesion Coverage Rate	68.2% (Single implantation)	97.5% (Single implantation)	Reduce repeated puncture trauma
Postoperative Normal Tissue Injury Rate	18.6%	3.2%	Improve patient postoperative recovery quality
Tumor Local Recurrence Rate (6-month follow-up)	22.3%	5.8%	Significantly improve long-term treatment efficacy

In addition to efficacy improvement, the operational advantages of diffuser fiber are also prominent in clinical minimally invasive surgery. Its ultra-flexible fiber body can pass through micro-catheters and accurately reach deep lesions such as visceral tumors and pelvic metastatic tumors that are difficult to access by traditional surgical instruments. The smooth biocompatible surface avoids tissue scratching and adhesion during implantation and extraction, reducing intraoperative operation difficulty. For palliative treatment of advanced tumors and precise treatment of small early tumors, this minimally invasive, high-precision treatment mode greatly expands the clinical application scope of optical tumor therapy.

In clinical follow-up observation, patients treated with optimized diffuser fiber-assisted iPDT have shorter postoperative wound healing time, lower inflammatory reaction incidence, and better overall quality of life. This fully proves that excellent diffuser fiber performance is not only a technical upgrade of medical devices, but also an important support for improving clinical treatment level and patient prognosis.

Clinical Implantation Scene and Light Field Coverage of Diffuser Fiber in Tumor Interstitial Therapy

With the continuous development of precision minimally invasive medicine, diffuser fiber, as the core light-delivery medium of optical therapy, will become more widely used in tumor treatment, skin lesion repair, and inflammatory tissue intervention. Understanding its clinical application advantages is crucial for clinicians to standardize treatment operations and optimize individualized treatment plans.